Alkeon Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9M Sell
200,000
-125,000
-38% -$17.8M 0.04% 94
2025
Q4
$54.1M Buy
325,000
+75,000
+30% +$12.5M 0.09% 83
2025
Q3
$49M Sell
250,000
-150,000
-38% -$24.7M 0.07% 84
2025
Q2
$36.2M Hold
400,000
0.06% 85
2025
Q1
$23.9M Hold
400,000
0.05% 90
2024
Q4
$53M Buy
400,000
+150,000
+60% +$14.1M 0.11% 70
2024
Q3
$13.1M Buy
+250,000
New +$11.7M 0.02% 87

Other funds holding ALAB

Alkeon Capital Management's ALAB Position: Q1 2026 in Review

Alkeon Capital Management reduced its Astera Labs (ALAB) stake by 38% in Q1 2026, selling an estimated $17.8M and leaving 200,000 shares worth $21.9M. The position accounts for 0.04% of the portfolio, ranked #94.

Alkeon Capital Management first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $54.1M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Alkeon Capital Management held 200,000 shares of Astera Labs worth $21.9M as of Q1 2026.
  • Alkeon Capital Management sold 125,000 Astera Labs shares in Q1 2026, an estimated $17.8M.
  • Astera Labs made up 0.04% of Alkeon Capital Management's portfolio in Q1 2026, its #94 holding.
  • Alkeon Capital Management first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • Alkeon Capital Management's Astera Labs position peaked at $54.1M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Alkeon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.